BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-12-31
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: A$0.7 M
• Last 12 months FTD volume: A$4.87 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	A$6.55 M	A$21.87 M	🇺🇸 USA
Sarepta Therapeutics SRPT	A$3.41 M	A$20.54 M	🇺🇸 USA
NanoViricides NNVC	A$1.38 M	A$5.1 M	🇺🇸 USA
Novavax NVAX	A$15.42 M	A$62.32 M	🇺🇸 USA
Gilead Sciences GILD	A$30.94 M	A$0.24 B	🇺🇸 USA
Celldex Therapeutics CLDX	A$6.56 M	A$11.6 M	🇺🇸 USA
GSK plc GSK	A$49.05 M	A$0.36 B	🇬🇧 UK
Emergent BioSolutions EBS	A$0.79 M	A$4.53 M	🇺🇸 USA
Cel-Sci CVM	N/A	A$0.38 M	🇺🇸 USA